Panagora Asset Management
ESPR icon

Panagora Asset Management’s Esperion Therapeutics ESPR Stock Holding History

Panagora Asset Management’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11,380
Closed -$70.9K – 1465
2022
Q4 		$70.9K Sell
11,380
-20,633
-64% -$148K ﹤0.01% 1419
2022
Q3 		$214K Buy
32,013
+11,342
+55% +$77.9K ﹤0.01% 1357
2022
Q2 		$131K Buy
+20,671
New +$117K ﹤0.01% 1428
2016
Q1 		– Sell
-1,591
Closed -$35K – 2304
2015
Q4 		$35K Buy
1,591
+1,052
+195% +$26.5K ﹤0.01% 2065
2015
Q3 		$13K Sell
539
-663
-55% -$41.6K ﹤0.01% 2196
2015
Q2 		$98K Sell
1,202
-1,484
-55% -$145K ﹤0.01% 1952
2015
Q1 		$249K Buy
2,686
+740
+38% +$47.8K ﹤0.01% 1587
2014
Q4 		$79K Hold
1,946
– – ﹤0.01% 1911
2014
Q3 		$47K Sell
1,946
-854
-31% -$13.6K ﹤0.01% 2037
2014
Q2 		$44K Sell
2,800
-1,135
-29% -$16.4K ﹤0.01% 2114
2014
Q1 		$59K Buy
3,935
+2,800
+247% +$43.5K ﹤0.01% 2054
2013
Q4 		$16K Sell
1,135
-13,630
-92% -$198K ﹤0.01% 2111
2013
Q3 		$278K Buy
+14,765
New +$248K ﹤0.01% 1538

Other funds holding ESPR

Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bellevue Group
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return

Panagora Asset Management's ESPR Position: Q1 2023 in Review

Panagora Asset Management sold out of Esperion Therapeutics (ESPR) in Q1 2023, closing a stake of 11,380 shares — an estimated $70.9K sold.

Panagora Asset Management first reported a position in ESPR in Q3 2013 and held it in 13 quarters. The position peaked at $278K in Q3 2013. 164 funds tracked by Wall St. Rank hold ESPR as of Q1 2023.

  • Panagora Asset Management reported no remaining Esperion Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Panagora Asset Management sold 11,380 Esperion Therapeutics shares in Q1 2023, an estimated $70.9K.
  • Panagora Asset Management first reported a position in Esperion Therapeutics in Q3 2013 and held it in 13 quarters.
  • Panagora Asset Management's Esperion Therapeutics position peaked at $278K in Q3 2013.
  • 164 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q1 2023.

Based on Panagora Asset Management's 13F filing for Q1 2023, filed 12 May 2023.